Your browser doesn't support javascript.
loading
A genetic modifier suggests that endurance exercise exacerbates Huntington's disease.
Corrochano, Silvia; Blanco, Gonzalo; Williams, Debbie; Wettstein, Jessica; Simon, Michelle; Kumar, Saumya; Moir, Lee; Agnew, Thomas; Stewart, Michelle; Landman, Allison; Kotiadis, Vassilios N; Duchen, Michael R; Wackerhage, Henning; Rubinsztein, David C; Brown, Steve D M; Acevedo-Arozena, Abraham.
Afiliação
  • Corrochano S; Mammalian Genetics Unit, Harwell Institute, Medical Research Council, Oxfordshire, UK.
  • Blanco G; Department of Biology, University of York, York, UK.
  • Williams D; Mammalian Genetics Unit, Harwell Institute, Medical Research Council, Oxfordshire, UK.
  • Wettstein J; Institute of Medical Sciences, University of Aberdeen, Scotland, UK.
  • Simon M; Mammalian Genetics Unit, Harwell Institute, Medical Research Council, Oxfordshire, UK.
  • Kumar S; Mammalian Genetics Unit, Harwell Institute, Medical Research Council, Oxfordshire, UK.
  • Moir L; Mammalian Genetics Unit, Harwell Institute, Medical Research Council, Oxfordshire, UK.
  • Agnew T; Mammalian Genetics Unit, Harwell Institute, Medical Research Council, Oxfordshire, UK.
  • Stewart M; Mammalian Genetics Unit, Harwell Institute, Medical Research Council, Oxfordshire, UK.
  • Landman A; Mammalian Genetics Unit, Harwell Institute, Medical Research Council, Oxfordshire, UK.
  • Kotiadis VN; Department of Cell and Developmental Biology, University College London (UCL), London, UK.
  • Duchen MR; Department of Cell and Developmental Biology, University College London (UCL), London, UK.
  • Wackerhage H; Institute of Medical Sciences, University of Aberdeen, Scotland, UK.
  • Rubinsztein DC; Department of Sport and Health Sciences, Technical University of Munich (TUM), Exercise Biology, Munich, Germany.
  • Brown SDM; Department of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, UK.
  • Acevedo-Arozena A; UK Dementia Research Institute, University of Cambridge, Cambridge, UK.
Hum Mol Genet ; 27(10): 1723-1731, 2018 05 15.
Article em En | MEDLINE | ID: mdl-29509900
ABSTRACT
Polyglutamine expansions in the huntingtin gene cause Huntington's disease (HD). Huntingtin is ubiquitously expressed, leading to pathological alterations also in peripheral organs. Variations in the length of the polyglutamine tract explain up to 70% of the age-at-onset variance, with the rest of the variance attributed to genetic and environmental modifiers. To identify novel disease modifiers, we performed an unbiased mutagenesis screen on an HD mouse model, identifying a mutation in the skeletal muscle voltage-gated sodium channel (Scn4a, termed 'draggen' mutation) as a novel disease enhancer. Double mutant mice (HD; Scn4aDgn/+) had decreased survival, weight loss and muscle atrophy. Expression patterns show that the main tissue affected is skeletal muscle. Intriguingly, muscles from HD; Scn4aDgn/+ mice showed adaptive changes similar to those found in endurance exercise, including AMPK activation, fibre type switching and upregulation of mitochondrial biogenesis. Therefore, we evaluated the effects of endurance training on HD mice. Crucially, this training regime also led to detrimental effects on HD mice. Overall, these results reveal a novel role for skeletal muscle in modulating systemic HD pathogenesis, suggesting that some forms of physical exercise could be deleterious in neurodegeneration.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atrofia Muscular / Doença de Huntington / Canal de Sódio Disparado por Voltagem NAV1.4 Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atrofia Muscular / Doença de Huntington / Canal de Sódio Disparado por Voltagem NAV1.4 Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article